IP Library Granted Patent US 7,101,565
Granted Patent B2
US 7,101,565 · App. 10/068,750 · Granted Sep 5, 2006

Probiotic/prebiotic composition and delivery method

Assignee: Corpak MedSystems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,101,565
App. No.
10/068,750
Granted
Sep 5, 2006
Kind
B2
Abstract

A prebiotic, composition comprising a probiotic and prebiotic, and method of delivering a probiotic, prebiotic or composition directly into the intestinal tract of a mammal are disclosed. The probiotic is any beneficial bacteria and the prebiotic is a substance beneficial to a probiotic. Most preferably, the prebiotic includes a mucopolysaccharide. The method preferably involves delivering the prebiotic, probiotic or composition via a delivery tube, such as an enteral feeding tube, directly to a position downstream of the stomach, most preferably to the jejunum.

Claims (61)

1. A composition comprising a probiotic and a prebiotic with the proviso that the prebiotic is not agar.

2. The composition of claim 1 wherein the probiotic comprises one or more bacteria from the group consisting of Bifidobacteria and Lactobacillus.

3. The composition of claim 1 wherein the prebiotic comprises a mucopolysaccharide.

4. The composition of claim 3 that further comprises pectin.

5. The composition of claim 3 wherein the prebiotic comprises one or more of the group consisting of chitin, and carraganan.

6. The composition of claim 3 wherein the prebiotic comprises chitin.

7. The composition of claim 3 wherein the probiotic comprises one or more of the bacteria of the group consisting of Bifidobacteria and Lactobacilli.

8. The composition of claim 3 wherein the probiotic comprises a Lactobacilli.

9. The composition of claim 8 wherein the probiotic comprises one or more of the group comprising L. acidophilus, L. casei, L. fermentum, L. salivaroes, L. brevis, L. leichmannii, L. plantarum and L. cellobiosius.

10. The composition of claim 3 wherein the probiotic comprises B. adolescentis.

11. The composition of claim 3 wherein the probiotic comprises L. acidophilus.

12. The composition of claim 3 that is formed as part of a tablet.

13. The composition of claim 3 that is contained within a capsule.

14. The composition of claim 3 that includes 10 6 or more probiotic.

15. The composition of claim 3 that includes 0.1-10% probiotic and 90-99.9% prebiotic.

16. The composition of claim 3 that further comprises an oligosaccharide.

17. The composition of claim 15 that further comprises an oligosaccharide.

18. A method of directly introducing into the gastrointestinal tract of a human, downstream of the stomach, the composition of claim 1 .

19. A method of directly introducing into the gastrointestinal tract of a human, downstream of the stomach, the composition of claim 3 .

20. The method of claim 18 wherein the composition of claim 1 is introduced directly into the jejunum.

21. The method of claim 19 wherein the composition of claim 3 is introduced directly into the jejunum.

22. The composition of claim 3 wherein the composition is agglomerated into particles and then dried.

23. A method of introducing into the intestinal tract of a human, downstream of the stomach, a beneficial substance, by utilizing a delivery tube having a first end upstream of the stomach and a second end in the gastrointestinal tract downstream of the stomach, the method comprising:

(a) introducing the beneficial substance into the first end of the delivery tube; and

(b) allowing the beneficial substance to exit the second end of the delivery tube where it enters the intestinal tract downstream of the stomach.

24. The method of claim 23 wherein the beneficial substance is a prebiotic.

25. The method of claim 23 wherein the beneficial substance is a probiotic.

26. The method of claim 23 wherein the beneficial substance is a composition comprising a prebiotic and a probiotic.

27. The method of claim 23 wherein the second end of the delivery tube is in the jejunum.

28. The method of claim 23 wherein the first end of the delivery tube is outside of the nose.

29. The method of claim 24 wherein the prebiotic includes an AG.

30. The method of claim 26 wherein the prebiotic includes an AG.

31. The method of claim 24 wherein the prebiotic includes a non-starch polysaccharide.

32. The method of claim 26 wherein the prebiotic includes a non-starch polysaccharide.

33. The method of claim 24 wherein the prebiotic includes a mucopolysaccharide.

34. The method of claim 26 wherein the prebiotic includes a mucopolysaccharide.

35. The method of claim 24 wherein the prebiotic includes an oligosaccharide.

36. The method of claim 26 wherein the prebiotic includes an oligosaccharide.

37. The method of claim 36 wherein the prebiotic includes a FOS.

38. The method of claim 37 wherein the prebiotic includes a FOS.

39. The method of claim 25 wherein the probiotic includes a Bifidobacteria.

40. The method of claim 26 wherein the probiotic includes a Bifidobacteria.

41. The method of claim 40 wherein the probiotic includes B. adolescentis.

42. The method of claim 41 wherein the probiotic includes B. adolescentis.

43. The method of claim 25 wherein the probiotic includes Bacteroides.

44. The method of claim 26 wherein the probiotic includes Bacteroides.

45. The method of claim 25 wherein 10 6 or greater probiotic are introduced into the first end of the delivery tube.

46. The method of claim 26 wherein 10 6 or greater probiotic are introduced into the first end of the delivery tube.

47. The method of claim 24 wherein the prebiotic includes inulin.

48. The method of claim 26 wherein the prebiotic includes inulin.

49. The method of claim 23 wherein the delivery to be is an enteral tube feeding device.

50. The method of claim 26 wherein the composition comprises 0.1-10% probiotic and 90-99.9% prebiotic.

51. The method of claim 26 wherein the composition comprises 1-10% probiotic and 90-99% prebiotic.

52. The method of claim 26 wherein the composition comprises 0.1-99% probiotic and 1-99.9% prebiotic.

53. The method of claim 24 wherein the prebiotic comprises one or more of the group consisting of chitin, and carraganan.

54. The method of claim 26 that comprises a mucopolysaccharide and an oligopolysaccharide.

55. The method of claim 26 wherein the prebiotic comprises one or more of the group consisting of chitin, and carraganan.

56. The method of claim 24 wherein the prebiotic has a particle size of 25 microns or less.

57. The method of claim 26 wherein the prebiotic has a particle size of 25 microns or less.

58. The method of claim 26 wherein the probiotic has a particle size of 25 microns or less.

59. The method of claim 23 wherein an enteral food is also introduced into the first end of the delivery tube and allowed to exit the second end of the delivery tube.

Assignments (9)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
RELEASE OF SECURITY INTEREST Recorded May 3, 2016
From: FIFTH THIRD BANK
To: CORPAK MEDSYSTEMS, INC.
Reel/Frame 038445/0887 →
SECURITY AGREEMENT Recorded Apr 12, 2013
From: CORPAK MEDSYSTEMS, INC.
To: FIFTH THIRD BANK
Reel/Frame 030205/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2010
From: MONTE, WOODROW C.
To: NESTEC LTD.
Reel/Frame 024358/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2007
From: CORPAK MEDSYSTEMS, INC.
To: MONTE, WOODROW C.
Reel/Frame 019910/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2002
From: MONTE, WOODROW C.
To: CORPAK MEDSYSTEMS, INC.
Reel/Frame 012574/0988 →
Continuity (1)
Related Publication 20040086491A2 · May 6, 2004